FGFR4 Arg388 genotype is associated with pathological complete response to neoadjuvant chemotherapy for primary breast cancer - Marmé, Frederik; Werft, Wiebke; Benner, Axel; Burwinkel, Barbara; Sinn, Peter; Sohn, Christof; Lichter, Peter; Hahn, Meinhard; Schneeweiss, Andreas (Annals of oncology, 2010)
Gesehen am 04.05.2023